Veerhealth Care Limited - 511523 - Results-Financial Results For March 31, 2022
Dear Sir, Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Statement showing the Audited Financial Results for the quarter and year ended March 31, 2022. 2. Auditors Report on the Audited Financial Results for the quarter and year ended March 31, 2022. 3. Declaration in respect of Audit Report with Unmodified Opinion. Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting
Dear Sir, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 30, 2022 as under: 1. The Board has approved and taken on record the Audited Financial Results for the quarter and year ended March 31, 2022. 2. The Board has not recommended final dividend on equity shares of the Company for the financial year 2021-22. The Board Meeting commenced at 5.00 p.m. and concluded at 6.00 p.m. Kindly take the above information on record and oblige. Veerhealth Care Limited - 511523 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Dear Sir, Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we hereby submit Annual Secretarial Compliance Report for the year ended 31st March, 2022. This is for your information and record. Veerhealth Care Limited - 511523 - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2022 And Recommendation Of Dividend, If Any.
Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve the Audited Financial Results for the quarter and financial year ended 31st March, 2022 and recommendation of dividend, if any. Veerhealth Care Limited - 511523 - Compliances-Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022
Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by M/s. Nidhi Shah & Associates, Practicing Company Secretary, for the year ended March 31, 2022. Kindly consider and take it in your record. Veerhealth Care Limited - 511523 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayVeerhealth Care Limited 2CINL65910MH1992PLC067632 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rony Shah Designation: Company Secretary EmailId: cs@veerhealthcare.net Name of the Chief Financial Officer: Akash Shah Designation: Chief Financial Officer EmailId: akash@veerhealthcare.net Date: 08/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Veerhealth Care Limited - 511523 - Compliances - Compliance Certificate For The Period Ended March 31, 2022
Dear Sir, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate, duly signed by Share Transfer Agent and the Compliance Officer of the Company for the year ended March 31, 2022 in compliance of Regulation 7(2) of SEBI Listing Regulations, 2015. Kindly consider and take it in your record. Veerhealth Care Limited - 511523 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bhavin S ShahDesignation :- Managing Director / Whole Time Director Veerhealth Care Limited - 511523 - Closure of Trading Window
Dear Sir, This is to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended, we wish to inform that the trading window for dealing in securities of the Company will remain closed from the end of quarter ended 31st March, 2022 till 48 hours after the declaration of financial results.